Al-Ameri M, et al. - This study was implemented to assess long-term survival as well as to identify prognostic factors to aid patient selection for pulmonary metastasectomy following colorectal cancer (CRC). During the study period, a steady increase in the number of post-CRC pulmonary metastasectomies was reported. Consistent with prior reports, prethoracotomy carcinoembryonic antigen (CEA) level was identified as a prognostic factor for long-term survival, and a 60% 5-year overall survival rate was reported, which was high in comparison with prior reports. Based on the observations, current patient selection criteria are reasonable, definitive evidence of efficacy is pending.